Zura Bio Limited
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | -96.3% | +1,816.4% | +78.0% | -36.5% | |
| – | +54.2% | +5,578.1% | +77.2% | -37.2% | |
| – | +114.9% | +6,269.2% | +76.8% | -38.0% | |
| – | +114.9% | +6,269.2% | +76.8% | -38.0% | |
| – | +163.9% | -22.1% | -8.4% | -36.4% | |
| – | +5,342.0% | +37.0% | -3.9% | -36.4% | |
| – | – | – | – | – | |
| – | +28,614.3% | +36.8% | -73.3% | +74.5% | |
| – | -124.6% | – | +147.5% | -30.8% | |
| – | – | – | – | – | |
| – | +0.0% | +91.7% | +127.0% | +25.4% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.